drugset / Trial / NCT00137787

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

NCT00137787

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to investigate whether intravenous ciprofloxacin is as effective as cefepime for the initial treatment of febrile neutropenia developed in patients with hematologic diseases.

Timeline

Start
2005-04
Primary completion
2009-12
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cefepime Small molecule 2 g Intravenous
Subject Ciprofloxacin Small molecule 300 mg Intravenous

Indications